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Abstract
Background: Cerebral palsy (CP) patients have motor limitations that can affect functionality and abilities for activities
of daily living (ADL). Health related quality of life and health status instruments validated to be applied to these patients
do not directly approach the concepts of functionality or ADL. The Child Health Assessment Questionnaire (CHAQ)
seems to be a good instrument to approach this dimension, but it was never used for CP patients. The purpose of the
study was to verify the psychometric properties of CHAQ applied to children and adolescents with CP.
Methods: Parents or guardians of children and adolescents with CP, aged 5 to 18 years, answered the CHAQ. A healthy
group of 314 children and adolescents was recruited during the validation of the CHAQ Brazilian-version. Data quality,
reliability and validity were studied. The motor function was evaluated by the Gross Motor Function Measure (GMFM).
Results: Ninety-six parents/guardians answered the questionnaire. The age of the patients ranged from 5 to 17.9 years
(average: 9.3). The rate of missing data was low (<9.3%). The floor effect was observed in two domains, being higher only
in the visual analogue scales (≤ 35.5%). The ceiling effect was significant in all domains and particularly high in patients
with quadriplegia (81.8 to 90.9%) and extrapyramidal (45.4 to 91.0%). The Cronbach alpha coefficient ranged from 0.85
to 0.95. The validity was appropriate: for the discriminant validity the correlation of the disability index with the visual
analogue scales was not significant; for the convergent validity CHAQ disability index had a strong correlation with the
GMFM (0.77); for the divergent validity there was no correlation between GMFM and the pain and overall evaluation
scales; for the criterion validity GMFM as well as CHAQ detected differences in the scores among the clinical type of CP
(p < 0.01); for the construct validity, the patients' disability index score (mean:2.16; SD:0.72) was higher than the healthy
group (mean:0.12; SD:0.23)(p < 0.01).
Conclusion: CHAQ reliability and validity were adequate to this population. However, further studies are necessary to
verify the influence of the ceiling effect on the responsiveness of the instrument.
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Background
Children and adolescents with cerebral palsy (CP) have
permanent and non-progressive development disorders.
In spite of medical treatment and rehabilitation, several
motor limitations can affect functionality and abilities for
activities of daily living (ADL) [1].
The need to know the effects of the disease on health con-
ditions and well-being through the eyes of the individual
or his/her caretaker has motivated countless efforts to
develop more useful instruments to evaluate the impact
experienced by patient and their families. These instru-
ments must have appropriate psychometric properties so
as to guarantee reliability, validity and sensitivity to
changes, and should be easy to apply and to interpret
[2,3].
In the past decade health status and health related quality
of life (HRQOL) instruments have been developed. Some
generic HRQOL questionnaires have already been used in
CP patients and have confirmed physical and psychoso-
cial impairment [4-9]. However, few specific instruments
(that measure health status or HRQOL) are available for
this population and they do not directly approach the
concepts related to functionality or ADL [10-15]. Thus,
evaluations of these concepts are greatly needed [16].
The Childhood Health Assessment Questionnaire
(CHAQ) is a specific instrument that evaluates functional
capacity and independence in ADL. CHAQ was con-
structed to evaluate children and adolescents with juve-
nile idiopathic arthritis [17], but this instrument has
already been applied to patients with current motor limi-
tations due to other chronic diseases like juvenile spond-
yloarthritis, spina bifida, articular hypermobility, juvenile
dermatomyositis, and lupus erythematosus [18-23]. This
instrument is easy to apply and interpret and it contains
useful concepts for the evaluation of patients with physi-
cal limitations like those with CP. The objective of the
present study was to verify the psychometric properties of
CHAQ as an instrument for the evaluation of children and
adolescents with CP.
Methods
Participants
Parents or legal guardians of children and adolescents
diagnosed with CP aged 5 to 18 years were invited to par-
ticipate in this cross-sectional study. The study was carried
out from December 2003 to April 2004 in a rehabilitation
center in the city of Uberlândia, Brazil (Associação de
Assistência à Criança Deficiente – AACD). Approval was
obtained from the Research Ethics Committee of the
center and written consent was obtained from the patients
or guardians. A control group representing the healthy
population, recruited on the occasion of the validation of
the Brazilian version of CHAQ, was also used [17].
Social and demographic data were obtained from the par-
ent/guardian and from the medical files. All patients were
submitted to neurological evaluation and classified
according to type of clinical manifestation and motor
function. Based on the clinical manifestation the patients
were distributed into: spastic, extrapyramidal and ataxic.
The spastic type was classified as hemiplegia, diplegia and
quadriplegia according to motor involvement [24]. The
motor function was evaluated according to the Gross
Motor Function Classification System (GMFCS) and the
patients were grouped into five levels [25]. Epilepsy was
diagnosed based on parent report and confirmed by the
medical record.
The parents/guardians answered the self-administered
CHAQ and were encouraged to fill out the blank items.
The Gross Motor Function Measure (GMFM) was applied
by a physical therapist for the evaluation of physical func-
tion [26].
Instruments
Child Health Assessment Questionnaire (CHAQ)
CHAQ is a specific instrument initially described as a
HRQOL evaluation questionnaire to be used in children
and adolescents with juvenile idiopathic arthritis, from
the perspective of the parent or patient. But the instru-
ment measures the functional capacity and independence
in ADL and has already been applied to patients with
other disabling conditions. It was translated, culturally
adapted and validated for the Portuguese language to be
used in Brazilian children and adolescents with juvenile
idiopathic arthritis, from the perspective of the parent or
legal guardian [17,27,28].
The questionnaire measures functional capacity and inde-
pendence during the last week of daily life activities. It is
made up of eight domains: dressing, arising, eating, walk-
ing, reach, grip, hygiene and  activities. For each domain
there is a 4 level difficulty scale that is scored from 0 to 3,
corresponding to "without any difficulty" (0), "with some
difficulty" (1), "with much difficulty" (2), and "unable to
do" (3). The option "not applicable" was also added in
the original elaboration of CHAQ; therefore some items
were not applied to some younger age groups. The higher
scores correspond to the highest degree of incapacity. The
average of the scores of the domains makes up the disabil-
ity index, which varies from 0 to 3 points.
CHAQ also presents two visual analogue scales for pain
evaluation and overall well-being evaluation. In the
present study, in the last question of the questionnaireHealth and Quality of Life Outcomes 2008, 6:109 http://www.hqlo.com/content/6/1/109
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that corresponds to the scale of overall evaluation, the
word "arthritis" was replaced with "cerebral palsy". This
was the only adaptation made in order to apply the instru-
ment to this study population.
The original English version of the CHAQ is available else-
where [28].
Gross Motor Function Measure (GMFM)
GMFM is a specific instrument developed for the purpose
of quantitatively measuring the changes in gross motor
function that occur in patients with CP over time [26]. It
consists of 88 items that are grouped into five dimensions
of gross motor function: lie down and roll (17 items), sit
down (20 items), crawl and kneel (14 items), stand (13
items), walk, run and jump (24 items). The final score of
the instrument is obtained by the average of the scores of
the five dimensions, varying from 0 to 100. The highest
scores indicate the best function.
GMFM was used as a measure of evaluation of physical
function that allowed comparisons with CHAQ.
Psychometric properties and statistical analysis [29]
Descriptive statistical analysis was used for the demo-
graphic and clinical characteristics of patients and inform-
ants. The characteristics of the participants and non-
participants (individuals who were invited to compose
the study group but did not consent or whose evaluations
were not concluded) were compared by Student's t-test
(for age) and the chi-square test.
The proportion of questionnaires that were not com-
pletely filled out (missing data) or items that were not
applicable were calculated for each domain and scale,
with ideal values being considered to be below 20%. The
rates of floor and ceiling effects were calculated as the pro-
portion of patients who obtained the lowest and highest
possible scores, respectively, of each domain or scale and
were considered to be present when they exceeded 10%.
The Shapiro-Wilk test was used to evaluate the normality
of the scores obtained with CHAQ and the normal distri-
bution of the data for both the study and control groups.
Internal consistency reliability was verified by the Cron-
bach alpha coefficient for each domain.
Item internal consistency was assessed and was consid-
ered to be satisfactory if the item achieved the minimum
correlation of 0.4 with the domains it represented and if
the success rate of the scale was higher than 80%.
The proportion of questionnaires with "not applicable"
items was calculated in order to study the face validity.
The correlation between questionnaires with "not appli-
cable" items and the following variables was verified: age,
classification of clinical type and score obtained by
GMFM.
Item-discriminant validity was determined to verify if
each item correlated more strongly with the concept it was
hypothesized to represent than with different concepts. It
was considered satisfactory if the success rate of the scale
was higher than 80%.
Discriminant validity is a test of the extent to which one
measure is not associated with other measures that are
hypothesized as not associated. It was tested by the corre-
lation between domains and disability index (that meas-
ures specific aspects of the functional capacity and ADL
activities) and the two scales (that measure general aspects
of HRQOL and pain). A weak correlation was expected
between the domains/disability index and the scale con-
struct.
Convergent validity was determined by the correlation of
the CHAQ domains and disability index with the GMFM.
A moderate to high correlation was expected. For diver-
gent validity the correlation between the CHAQ scales and
the GMFM was tested, and a poor coefficient was
expected.
The Pearson correlation coefficient was used for all corre-
lation tests.
Analysis of variance was used to verify the criteria or con-
current validity by comparing GMFM and CHAQ per-
formance according to CP classification. It was expected
that both instruments could distinguish could distinguish
the motor function limitation of each patient group in the
same manner. The Bonferroni test allowed the definition
of the differences between the averages of the groups.
Patients with ataxia were not included in this analysis due
to the small number found in the sample.
Student's t-test was used to determine construct validity
by comparing the scores for the patients with those for the
control group. The initial hypothesis was that the study
population had more functional limitations than the
healthy population. The correlation of the patients'
GMFCS levels and the CHAQ disability index scores was
used to confirm the hypothesis that the CHAQ construct
has a strong or moderate correlation with the motor func-
tion.
Results
Of the 126 eligible patients, 96 participated in the study.
The clinical and demographic characteristics of the
patients were similar for participants and non-partici-Health and Quality of Life Outcomes 2008, 6:109 http://www.hqlo.com/content/6/1/109
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pants (p > 0.05). No differences were detected between
the study and control group according to age (p = 1.15)
and gender (p = 0,07). The characteristics of the study
group are presented in Table 1.
The patients were predominantly represented by their
mothers (81 0%). The age of the informants ranged from
18 to 61 years (average = 34.8, standard deviation = 8.8).
Most of the informants had completed elementary school
(52.1%).
Psychometric properties of CHAQ
Data quality
The proportion of missing data was low and varied from
3.1% to 9.3% in the domains and scales (Table 2).
The floor effect was observed in three domains: arising
(26.0%), walking (13.7%) and grip (16%), and was signif-
icant in the visual analogue scales (26.1 to 35.5%) (Table
2). Comparison of the scores obtained according to the
classification of the clinical type of CP revealed that the
floor effect was greater in the hemiparetic group for the
arising (54.20%) and walking (37.5%) domains. In the
grip  domain, the highest proportions occurred in the
diparetic and hemiparetic groups (25.7% and 20.8%,
respectively). In the visual analogue scales all the groups
had high values for the floor effect.
The ceiling effect was detected and was high in all
domains (30.2 to 68.8%) and was not present in the vis-
ual analogue scales (Table 2). For the quadriplegia group,
the rate of the ceiling effect was very high in all domains,
ranging from 81.8 to 90.9%. In the extrapyramidal group,
the proportion of the ceiling effect was 45.4 to 91.0%, and
in the diparetic group it ranged from 14.3 to 65.7%, with
higher rates for the dressing (62.9%) and activities (65.7%)
domains. The hemiparetic group showed the lowest ceil-
ing effect rates, which were more significant only for the
dressing (54.2%) and activities (45.8%) domains.
Reliability
Reliability was adequate. The Cronbach alpha coefficient
ranged from 0.85 to 0.95. The success rate regarding item
internal consistency was 100% in all domains (Table 3).
Validity
In the determination of face validity, 28.1% of the ques-
tionnaires were found to present some "not applicable"
items. In 7.3% of the questionnaires there was only a sin-
gle item considered to be "not applicable", whereas in
9.4% of the questionnaires more than 6 items were "not
applicable", i.e., more than 20% of the items were "not
applicable". The rate of "not applicable" items according
to the domains ranged from 5.2 to 22.9%, and the activi-
ties domain was the only one that obtained values above
20% (22.9%). There was no correlation between the fre-
quency of "not applicable" items and the variables age,
clinical type of CP and score obtained by GMFM (p >
0.05).
The discriminant validity of the item obtained an appro-
priate success rate in six domains and was below the ideal
value for the dressing and activities domains (Table 4).
For the discriminant validity the correlation of the
domains and of the disability index with the visual ana-
logue scales was not significant. In general, the domains
presented strong to moderate correlations with one
another (Table 5).
The convergent validity was satisfactory because GMFM
presented a significant correlation with the CHAQ
domains and a strong correlation with the disability index
(0.77). The divergent validity was confirmed because
there was no correlation between GMFM and the pain and
overall evaluation scales (Table 6).
For the criterion validity it was observed that GMFM as
well as CHAQ detected differences in the scores among
the groups classified according to the clinical type of CP (p
Table 1: Demographic and clinical characteristics of the 
participants
Characteristics Participants
n = 96
Mean age (SD) 9.3 (3.4)
Male (%) 54 (56.3)
Ethnicity (%)
- Caucasian 68 (70.9)
- African-Brazilian 28 (29.1)
Classification of CP (%)
- spastic 81 (84.4)
. quadriplegia 22 (22.9)
. diplegia 35 (36.5)
. hemiplegia 24 (25.0)
- extrapyramidal 11 (11.5)
- ataxic 4 (4.1)
GMFCS
- level 1 39 (37,5)
- level 2 3 (3.1)
- level 3 20 (20.8)
- level 4 6 (6,25)
- level 5 28 (29.2)
GMFM – mean (SD) 56 (35.1)
Epilepsy (%) 44 (45.8)
Education (%)
- not receiving education 21 (21.9)
- receiving special education 29 (30.2)
- receiving regular education 46 (47.9)
SD = Standard deviationHealth and Quality of Life Outcomes 2008, 6:109 http://www.hqlo.com/content/6/1/109
Page 5 of 10
(page number not for citation purposes)
< 0.01), except for the visual analogue scales (p > 0.05).
Like the GMFM, the disability index and the arising domain
of CHAQ discriminated the differences among all clinical
types of CP analyzed. The walking domain also detected
differences among the three spastic subtypes of the dis-
ease. Patients with quadriplegia presented more physical
incapacities as determined by both instruments and in all
CHAQ domains (Table 7).
The hypothesis determined in the construct validity that
children and adolescents with CP have higher scores, or in
other words, more incapacity than the healthy population
was confirmed (p < 0.01) in all the CHAQ domains, scales
and disability index (Table 8).
A strong correlation of the patients' GMFCS levels and the
CHAQ disability index scores was obtained (r = 0.73).
Discussion
The results of the present study demonstrate that the psy-
chometric properties of the Brazilian version of CHAQ
were appropriate as a whole for the evaluation of HRQOL
in children and adolescents with CP, with possible limita-
tions related to the presence of a significant ceiling effect.
The rate of missing data was low, as also observed for the
healthy Brazilian population and for subjects with juve-
nile idiopathic arthritis [17], indicating good acceptability
and effort efforts by the informants in filling out the ques-
tionnaires.
The low frequency of the floor effect in the domains sug-
gests that the instrument is able to evaluate and to dis-
criminate patients with smaller motor incapacity. The
floor effect was greater for the arising, walking and gripping
domains only for the patients with the hemiparetic form
of the disease, and only for the gripping domain for the
patients with the diparetic form, i.e., this occurred for the
tasks executed with less difficulty by these children/ado-
lescents. In the visual analogue scales the floor effect was
significant in all the clinical forms of the disease, a fact
that may limit the evaluation of patients with less impair-
ment and a lower frequency of pain as perceived by the
parent/guardian.
The ceiling effect found in all domains suggests the possi-
bility of the instrument being insensitive to verify differ-
ences in HRQOL among the patients with greater motor
incapacity. Nevertheless, the instrument was as effective in
detecting differences in HRQOL between groups, as
Table 2: Data quality: missing data, floor and ceiling effects
CHAQ Missing data (%) Floor effect (%) Ceiling effect (%)
Dressing 6.2 3.1 68.8
Arising 3.1 26.0 30.2
Eating 3.1 6.3 45.8
Walking 3.1 13.7 41.1
Hygiene 6.2 3.2 47.9
Reach 7.3 7.4 40.4
Grip 6.2 16.0 40.4
Activities 9.3 2.1 68.1
Evaluation of pain 3.1 35.5 1.1
Evaluation of overall well-being 4.2 26.1 1.1
Table 3: Reliability: internal consistency reliability and item internal consistency
Domains Itens (n) Internal consistency reliabilitya Item internal consistency
Range of item correlationsb Success/Total Success Rate
Dressing 4 0.85 0.44 – 0.95 4/4 100
Arising 2 0.94 0.84 – 0.94 2/2 100
Eating 3 0.85 0.57 – 0.94 3/3 100
Walking 2 0.95 0.86 – 0.89 2/2 100
Hygiene 5 0.95 0.72 – 0.79 5/5 100
Reach 4 0.88 0.50 – 0.76 4/4 100
Grip 5 0.94 0.61 – 0.83 5/5 100
Activities 5 0.90 0.58–0.71 5/5 100
a Cronbach alpha coefficient
b Pearson's correlation coefficientHealth and Quality of Life Outcomes 2008, 6:109 http://www.hqlo.com/content/6/1/109
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GMFM, the instrument used as an external criterion for
the evaluation of physical function.
The predominance of the ceiling effect in the quadriplegia
and extrapyramidal group was expected since these
patients have more motor limitations and the instrument
used in the present study covers very specific functional
abilities. The great heterogeneity of the population stud-
ied hinders the elaboration of an appropriate question-
naire for the whole spectrum of possible motor
manifestations in this disease. The evaluation of HRQOL
should be complemented with more specific instruments
for the patient with greater motor difficulties caused by CP
[11,14].
The variability of the scores obtained with the instruments
of HRQOL is an indicator of good sensitivity in detecting
changes in health conditions. Because this was a cross-sec-
tional study, one of its limitations was the impossibility to
test the sensitivity and responsiveness of the instrument.
Prospective studies are necessary to evaluate this property
and to verify the influence of the floor and ceiling effects
on the sensitivity and responsiveness of CHAQ in chil-
dren and adolescents with CP over time or after interven-
tions. For a future longitudinal study the necessity to
include the quadriplegic group should be verified, as
CHAQ is an instrument that focuses on daily activities,
and we do not expect to have a significant modification
with the treatment program in this dimension for this
group (we should consider the very high CHAQ scores, in
all domains, with many ceiling effects to reinforce this
idea). Others instruments with others dimensions could
be more useful to evaluate the outcome of the quadriple-
gic group. But in this cross-sectional study we believe that
it was important to evaluate all motor forms of cerebral
palsy because it shows us that from the caregiver perspec-
tive these patients are very different in the domains meas-
ured by this instrument.
In general, CHAQ has been used to evaluate patients with
juvenile idiopathic arthritis and musculoskeletal diseases,
populations in which the percentage of individuals with
lower motor incapacity is high, generating a considerable
floor effect and an insignificant ceiling effect [17,19].
Modifications in the options of answers have already been
proposed by Lam et al. [19] for the evaluation of patients
with musculoskeletal diseases in order to improve the sen-
sitivity of the instrument and its ability to distinguish
between patients with milder motor difficulties and the
control groups. For the specific population with CP,
changes could be made in the questionnaire in order to
Table 4: Item discriminant validity
Domains Itens (n) Range of item correlationsa Success/Total Success Rate (%)
Dressing 4 0.34 – 0.95 13/32 40.6
Arising 2 0.35 – 0.94 16/16 100.0
Eating 3 0.32 – 0.94 22/24 91.7
Walking 2 0.41 – 0.89 16/16 100.0
Hygiene 5 0.43 – 0.76 40/40 100.0
Reach 4 0.28 – 0.76 21/24 87.5
Grip 5 0.38 – 0.83 39/40 97.5
Activities 5 0.36 – 0.71 29/40 72.5
aPearson's correlation coefficient
Table 5: Discriminant validity: correlation between CHAQ domains and disability index with the scales
CHAQ Dressing Arising Eating Walking Hygiene Reach Grip Activities D. Index E. pain E. overall
Dressing 1.00*
Arising 0.29* 1.00*
Eating 0.68* 0.43* 1.00*
Walking 0.43* 0.66* 0.51* 1.00*
Hygiene 0.72* 0.56* 0.66* 0.62* 1.00*
Reach 0.42* 0.47* 0.48* 0.54* 0.55* 1.00*
Grip 0.57* 0.56* 0.65* 0.55* 0.67* 0.44* 1.00*
Activities 0.51* 0.38* 0.46* 0.53* 0.55* 0.33* 0.50* 1.00*
D. Index 0.72* 0.74* 0.78* 0.77* 0.86* 0.69* 0.82* 0.66* 1.00*
E. pain -0.04 0.05 0.00 0.01 -0.05 0.20 0.08 0.06 0.07 1.00*
E. overall 0.10 0.06 0.09 0.12 0.13 0.07 0.11 0.10 0.17 0.52* 1.00*
*Pearson's correlation coefficient was significant at the 0.01 level
D. Index. = Disability Index; E. pain = Evaluation of pain; E. overall = Evaluation of overall well-beingHealth and Quality of Life Outcomes 2008, 6:109 http://www.hqlo.com/content/6/1/109
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reduce the ceiling effect and to improve the differentiation
of more seriously affected individuals.
In spite of these considerations, the results of the present
study demonstrated that the instrument was capable of
detecting differences among all the types of CP for the dis-
ability index and for the arising  domain. Most of the
domains detected more difficulties in the quadriplegia
group compared to the diparetic and hemiparetic groups,
although they did not differentiate the latter groups from
one another, except for the arising and walking domains.
Limitations were observed in the visual analogue scales
which are more generic and subjective.
Reliability was found to be appropriate for all domains
and the variations found in the correlation coefficient
between the items and the domain itself did not suggest
redundancy in the questions. The validity was also shown
to be generally appropriate for the aspects tested.
In the evaluation of the face validity the instrument was
considered appropriate for the study population on the
basis of the perception of the informant. The face validity
is the extent to which a measure "looks like" what it is
intended to measure [29]. In other words, to verify this
validity it is necessary to ask the respondent, during com-
pletion of the measure, whether the items and scales look
reasonable at "face value".
The category of "not applicable" answers was introduced
in the original elaboration of CHAQ as an option for
younger children, although each domain presents at least
one question that can be answered by children under nine
years. However, we believe that further information can
be obtained when analyzing the proportion of "not appli-
cable" items, because this type of answer suggests inade-
quacy of the question which is not due only to the
influence of the age factor but also to the motor limitation
of the patient. Therefore the proportion of questionnaires
with "not applicable" items for each domain was analyzed
and shown to be useful in the evaluation of face validity
in the present study. If the parents/guardians say that the
item is "not applicable" we need to think about the value
of this question for these patients. The opportunity to
have this option in the original version of CHAQ and to
use it to access the face validity was very important. It was
the first time that this option was used for this purpose in
the instrument but future studies should not miss the
opportunity offered by the instrument.
Table 6: Convergent and divergent validity: correlation between 
CHAQ and GMFM
CHAQ Correlation with GMFM (r)
Dressing -0.43*
Arising -0.79*
Eating -0.56*
Walking -0.72*
Hygiene -0.65*
Reach -0.53*
Grip -0.57*
Activities -0.41*
Disability Index -0.77*
Evaluation of pain -0.14
Evaluation of overall well-being -0.19
*Pearson's correlation coefficient was significant at the 0.01 level
Table 7: CHAQ and GMFM mean scores, according to the CP classification
CHAQ Spastic Extrap
(n = 11)
p value*
Quadri
(n = 22)
Dip
(n = 35)
Hemi
(n = 24)
Dressing 2.91a 2.43ab 2.33b 2.91ab 0.01
Arising 2.86a 1.49b 0.62c 2.09d 0.00
Eating 2.82a 2.00b 1.83b 2.36ab 0.00
Walking 2.86a 2.26b 0.87c 2.18b 0.00
Hygiene 2.90a 2.21bc 1.79b 2.64ac 0.00
Reach 2.90a 2.00b 1.83b 2.36b 0.00
Grip 2.90a 1.68b 1.50b 2.36a 0.00
Activities 2.90a 2.50ab 2.25b 2.82a 0.01
Disability Index 2.90a 2.03b 1.64c 2.47d 0.00
Evaluation of pain 0.67a 0.30a 0.59a 0.11a 0.09
Evaluation of overall well-being 0.74a 0.43a 0.48a 0.57a 0.59
GMFM 10.59a 63.51b 89.50c 42.45d 0.00
*ANOVA. Mean scores followed by the same letter do not differ from each other by the Bonferroni post hoc test.
Quadri = quadriplegia; Dip = diplegia; Hemi = hemiplegia; Extrap = extrapyramidalHealth and Quality of Life Outcomes 2008, 6:109 http://www.hqlo.com/content/6/1/109
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For the study population, the presence of "not applicable"
questions was expected considering the age range evalu-
ated and the motor limitation of the patient. Although
this type of answer was frequent in the study population
as a whole, the proportion of questionnaires with more
than 20% of "non-applicable" items was low and the
value was a little higher only in the activities domain. Since
the frequency of "not applicable" items was low, when
considering the questionnaire as a whole, the correlations
of this type of answer with age, clinical type and physical
function determined by GMFM were not significant. The
values obtained demonstrate that CHAQ is adequate for
the evaluation of the functional capacity of children and
adolescents with CP as a whole, according to the percep-
tion of the parents/guardians.
In the evaluation of the discriminant validity of the items
the success rate in the dressing and activities domains was
below the ideal level. Since this is a specific instrument,
different from multidimensional questionnaires, it is
understood that some items may correlate with more than
one domain. For the Brazilian population with juvenile
idiopathic arthritis and for healthy controls, the discrimi-
nant validity of the items failed in the dressing, walking and
reaching domains [17]. These data may suggest the need to
review some items and to rearrange them into more
homogeneous domains according to the concepts
involved, but this does not represent a limitation of the
use of the instrument.
From the discriminant validity it was expected that the
instrument could discriminate different constructs. Actu-
ally, the analysis showed that the visual analogue scales
really evaluate concepts that differ from the domains and
the  disability index, with non-significant correlations
between them. Moderate and significant correlations
among the domains were expected because a specific
instrument only involving the physical dimension in the
evaluation of functional capacity was used. These con-
cepts were again confirmed when correlating GMFM, the
specific instrument for the evaluation of physical func-
tion, with the CHAQ domains which corresponded to
appropriate convergent validity. The absence of correla-
tion of GMFM with CHAQ scales confirmed the different
natures of the measured constructs and demonstrated
appropriate divergent validity.
Moreover, GMFM served as an external criterion to verify
differences among the clinical types of CP. CHAQ proved
to be capable of detecting these differences in all domains,
but mainly for the disability index and for the arising
domain. The visual analogue scales were not as useful as
the GMFM in the evaluation of the clinical types of CP.
This result was expected because GMFM was not consid-
ered an external criterion for these scales since they deal
with different domains.
The hypothesis raised for construct validity was satisfied,
because CHAQ proved to be useful to discriminate the
performance of the healthy population and the patients
with CP as a whole in all the domains and scales and the
disability index.
The high but not perfect correlation between disability
index and GMFCS levels in the present study indicates that
CHAQ has a strong correlation with the gross motor func-
tion, but it is built to measure others aspects of the physi-
cal construct, as hypothesized.
Table 8: CHAQ mean scores for the patient and healthy groups
CHAQ Mean (SD) Differences among mean scores p value*
Healthy
(n = 314)
Patient
(n = 96)
Dressing 0.34 (0.66) 2.53 (0.79) 2.19 0.00
Arising 0.01(0.13) 1.62 (1.17) 1.61 0.00
Eating 0.16 (0.42) 2.18 (0.92) 2.02 0.00
Walking 0.00 (0.00) 2.03 (1.04) 2.03 0.00
Hygiene 0.08 (0.32) 2.28 (0.82) 2.20 0.00
Reach 0.10 (0.31) 2.15 (0.89) 2.05 0.00
Grip 0.08 (0.35) 1.97 (1.08) 1.89 0.00
Activities 0.20 (0.47) 2.56 (0.73) 2.36 0.00
Disability Index 0.12 (0.23) 2.16 (0.72) 2.04 0.00
Evaluation of pain 0.02 (0.20) 0.42 (0.65) 0.40 0.00
Evaluation of overall well-being 0.01 (0.07) 0.53 (0.62) 0.52 0.00
* Student t test
SD = Standard deviationHealth and Quality of Life Outcomes 2008, 6:109 http://www.hqlo.com/content/6/1/109
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It is essential to examine the measuring properties of the
instruments used in the evaluation of health status or
HRQOL for the interpretation of the results and for the
best applicability of these instruments in clinical practice.
The present study should be interpreted by considering
possible inherent methodological limitations. Although
CHAQ can be answered by the patient, in this study only
the information provided by the parent/guardian was
considered. Most of the studies of this nature generally
resort to a relative to obtain information. Few studies have
obtained the perception of the patient with cerebral palsy
and they did not involve representatives of the total pop-
ulation suffering from this disease [15,30,31]. When
working with children with developmental disorders, fre-
quently not only physical but various other levels of com-
munication delay, cognitive deficit, learning disability
make the presence of a representative essential [2,32].
Due to these limitations, the presence of a representative
of the child or of the patients with developmental disor-
ders has the advantage of providing further information
about the health conditions and well-being of the patients
in addition to the perspective of the health team, even if
that implies a potential risk of increasing subjectivity.
Future studies should be conducted to determine the pos-
sibility of applying CHAQ directly to the patients with CP,
although patients with cognitive limitations should be
excluded. The psychometric properties should also be
analyzed again for each population group studied.
Others instruments more frequently used in patients with
CP to measure the child's performance by parent report
like the Pediatric Evaluation of Disability Inventory
(PEDI) and the Functional Independence Measure for
children (WeeFIM) include a self-care scale [5,16] and
they also show a high correlation with GMFM and
GMFCS. The Pediatric Quality of Life Inventory (Ped-
sQOL) – Cerebral Palsy Module, a HRQOL specific instru-
ment, has adequate reliability and validity but only
includes few questions about ADL [15]. So, these instru-
ments do not provide information about abilities for
activities of daily living they are only available in English.
CHAQ is a more specific instrument and it is available in
at least 32 countries [28]. It would be useful to apply it in
association with a generic HRQOL instrument.
Conclusion
CHAQ reliability and validity were adequate to evaluate
children and adolescents with cerebral palsy. However,
further studies are necessary to verify the influence of the
ceiling effect on the responsiveness of the instrument,
mainly in the evaluation of patients with quadriplegia.
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